Download PDF
Vet Comp Orthop Traumatol 2011; 24(04): 285-288
DOI: 10.3415/VCOT-10-07-0111
Brief Communication
Schattauer GmbH

The use of cyclosporine-A in dogs with chronic osteoarthritis: A pilot study

C. H. de Mello Souza
1   Small Animal Clinical Sciences, College of Veterinary Medicine, The University of Tennessee, Knoxville, Tennessee, USA
,
J. Headrick
1   Small Animal Clinical Sciences, College of Veterinary Medicine, The University of Tennessee, Knoxville, Tennessee, USA
,
J. P. Weigel
1   Small Animal Clinical Sciences, College of Veterinary Medicine, The University of Tennessee, Knoxville, Tennessee, USA
,
D. L. Millis
1   Small Animal Clinical Sciences, College of Veterinary Medicine, The University of Tennessee, Knoxville, Tennessee, USA
› Author Affiliations
Further Information

Publication History

Received:16 July 2010

Accepted:10 April 2011

Publication Date:
21 December 2017 (online)

  PDF Download  Permissions and Reprints

Summary

Objective: To evaluate the efficacy of cyclosporine-A in dogs with radiographic and physical evidence of chronic stifle osteoarthritis.

Materials and methods: Ten hound-type dogs with osteoarthritis induced by surgical transection of a cranial cruciate ligament followed by immediate stabilization of the stifle four years prior to study start were randomized to two groups. Cyclosporine-A was administered orally once daily at 5 mg/kg to one group for one month while the other group served as control. After a two week wash-out period during which the animals were not treated, and the degree of lameness was allowed to return to baseline, the treatments were switched so that the second group received treatment with cyclosporine-A and the first group served as control. Ground reaction forces were measured using a force platform in all animals at day zero and then every two weeks until the end of the study.

Results: Cyclosporine-A did not alter the degree of lameness based on assessment of ground reaction forces.

Conclusions: At a dose of 5 mg/kg/day for 28 days, cyclosporine-A was not effective in decreasing lameness of dogs with chronic osteoarthritis induced by surgical transection of the cranial cruciate ligament.

Keywords

Osteoarthritis - cyclosporine-A - cranial cruciate ligament
 

  • References

  • 1 Vasseur PB, Berry CR.. Progression of stifle osteoarthritis following reconstruction of the cranial cruciate ligament in 21 dogs. J Am Anim Hosp Assoc 1992; 28: 129-136.
    PubMedGoogle Scholar
  • 2 Hay CW, Chu Q, Budsberg SC. et al. Synovial fluid interleukin 6, tumor necrosis factor, and nitric oxide values in dogs with osteoarthritis secondary to cranial cruciate ligament rupture. Am J Vet Res 1997; 58: 1027-1032.
    PubMedGoogle Scholar
  • 3 Trumble TN, Billinghurst RC, McIlwraith CW.. Correlation of prostaglandin E2 concentrations in synovial fluid with ground reaction forces and clinical variables for pain or inflammation in dogs with osteoarthritis induced by transection of the cranial cruciate ligament. Am J Vet Res 2004; 65: 1269-1275.
    CrossrefPubMedGoogle Scholar
  • 4 Muir P, Danova NA, Argyle DJ. et al. Collagenolytic protease expression in cranial cruciate ligament and stifle synovial fluid in dogs with cranial cruciate ligament rupture. Vet Surg 2005; 34: 482-490.
    CrossrefPubMedGoogle Scholar
  • 5 Fujita Y, Hara Y, Nezu Y. et al. Proinflammatory cytokine activities, matrix metalloproteinase-3 activity, and sulphated glycosaminoglycan content in synovial fluid of dogs with naturally acquired cranial cruciate ligament rupture. Vet Surg 2006; 35: 369-376.
    CrossrefPubMedGoogle Scholar
  • 6 Renberg WC.. Pathophysiology and management of arthritis. Vet Clin North Am Small Anim Pract 2005; 35: 1073-1091.
    CrossrefPubMedGoogle Scholar
  • 7 Sutton S, Clutterbuck A, Harris P. et al. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J 2009; 179: 10-24.
    CrossrefPubMedGoogle Scholar
  • 8 Winkler M.. Cyclosporine as baseline immunosuppression in solid organ transplantation. Bio Drugs 2000; 14: 185-193.
    PubMedGoogle Scholar
  • 9 Gregory CR, Kyles AE, Bernstein L. et al. Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy. Vet Surg 2006; 35: 105-112.
    CrossrefPubMedGoogle Scholar
  • 10 Murray KJ, Lovell DJ.. Advanced therapy for juvenile arthritis. Best Pract Res Clin Rheumatol 2002; 16: 361-378.
    CrossrefPubMedGoogle Scholar
  • 11 Soriano ER, McHugh NJ.. Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J Rheumatol 2006; 33: 1422-1430.
    PubMedGoogle Scholar
  • 12 Niemeyer GP, Welch JA, Tilson M. et al. Renal allo-graft tolerance in DLA-identical and haplo-identical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil. Transplant Proc 2005; 37: 4579-4586.
    CrossrefPubMedGoogle Scholar
  • 13 Rapaport FT, Meek AG, Arnold AN. et al. Preoperative preparation of high-risk, specifically hyper-immunized canine renal allograft recipients with total lymphoid irradiation and cyclosporine. Transplantation 1987; 44: 185-195.
    CrossrefPubMedGoogle Scholar
  • 14 Olivero DK, Davidson MG, English RV. et al. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs. J Am Vet Med Assoc 1991; 199: 1039-1042.
    PubMedGoogle Scholar
  • 15 Mathews KA, Ayres SA, Tano CA. et al. Cyclosporine treatment of perianal fistulas in dogs. Can Vet J 1997; 38: 39-41.
    PubMedGoogle Scholar
  • 16 Marsella R.. Calcineurin inhibitors: a novel approach to canine atopic dermatitis. J Am An Hosp Assoc 2005; 41: 92-97.
    PubMedGoogle Scholar
  • 17 Steffan J, Favrot C, Mueller R.. A systematic review and meta-analysis of the efficacy and safety of cyclosporine for the treatment of atopic dermatitis in dogs. Vet Dermatol 2006; 17: 3-16.
    CrossrefPubMedGoogle Scholar
  • 18 Crespo-Leiro MG.. Calcineurin inhibitors in heart transplantation. Transpl Proc 2005; 37: 4018-4020.
    CrossrefPubMedGoogle Scholar
  • 19 Yoo SA, Park BH, Park GS. et al. Calcineurin is expressed and plays a critical role in inflammatory arthritis. J Immunol 2006; 177: 2681-2690.
    CrossrefPubMedGoogle Scholar
  • 20 Lufft V, Linneweber S, Lonnemann G.. Differential modulation of synthesis of human IL-1 beta and IL-1 receptor antagonist by cyclosporine A. Transpl Proc 2002; 34: 1130-1132.
    CrossrefPubMedGoogle Scholar
  • 21 Russell RG, Graveley R, Skjodt H.. The effects of cyclosporine-A on bone and cartilage. Br J Rheumatol 1993; 32: 42-46.
    PubMedGoogle Scholar
  • 22 Garcia JE, Lopez AM, de Cabo MR. et al. Cyclosporin A decreases human macrophage interleukin-6 synthesis at post-transcriptional level. Mediators Inflamm 1999; 8: 253-259.
    CrossrefPubMedGoogle Scholar
  • 23 Cho ML, Kim WU, Min DJ. et al. Cyclosporine differentially regulates interleukin-10, interleukin-15 and tumor necrosis factor production by rheumatoid synoviocytes. Arthritis Rheum 2002; 46: 42-51.
    CrossrefPubMedGoogle Scholar
  • 24 Attur MG, Patel R, Thakker G. et al. Differential anti-inflammatory effects of immunosuppressive drugs cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, cyclooxygenase-2 and PGE-2 production. Inflamm Res 2000; 49: 20-26.
    CrossrefPubMedGoogle Scholar
  • 25 Cho ML, Cho CS, Min SY. et al. Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Arthritis Rheum 2002; 46: 1202-1209.
    CrossrefPubMedGoogle Scholar
  • 26 Little CB, Hughes CE, Curtis CL. et al. Cyclosporin A inhibition of aggrecanase-mediated proteoglycans catabolism in articular cartilage. Arthritis Rheum 2002; 46: 124-129.
    CrossrefPubMedGoogle Scholar
  • 27 Seales EC, Micoli KJ, McDonald JM.. Calmodulin is a critical regulator of osteoclastic differentiation, function, and survival. J Cell Biochem 2006; 97: 45-55.
    CrossrefPubMedGoogle Scholar
  • 28 Cutolo M, Barone A, Accardo S. et al. Effect of cyclosporin on apoptosis in human cultures monocytic THP-1 cells and synovial macrophages. Clin Exp Rheumatol 1998; 16: 417-422.
    PubMedGoogle Scholar
  • 29 Barrett JG, Zhengling H, Graf BK. et al. Inflammatory changes in ruptured canine cranial and human anterior cruciate ligaments. Am J Vet Res 2005; 66: 2073-2080.
    CrossrefPubMedGoogle Scholar
  • 30 House AK, Guitian J, Gregory SP. et al. Evaluation of the effect of two dose rates of cyclosporine on the severity of perianal fistulae lesions and associated clinical signs in dogs. Vet Surg 2006; 35: 543-549.
    CrossrefPubMedGoogle Scholar
  • 31 Patricelli AJ, Hardie RJ, McAnulty JF.. Cyclosporine and ketoconazole for the treatment of perianal fistulas in dogs. J Am Vet med Assoc 2002; 220: 1009-1016.
    CrossrefPubMedGoogle Scholar
  • 32 Hegemann N, Wondimu A, Kohn B. et al. Cytokine profile in canine immune-mediated polyarthritis and osteoarthritis. Vet Comp Orthop Traumatol 2005; 18: 67-72.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Yoo SA, Park BH, Park GS, Koh HS. et al. Calcineurin is expressed and plays a critical role in inflammatory arthritis. J Immunol 2006; 177: 2681-2690.
    CrossrefPubMedGoogle Scholar